(RRC) Range Resources - Overview
Stock: Gas, Liquids, Oil
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 0.95% |
| Yield on Cost 5y | 3.77% |
| Yield CAGR 5y | 31.04% |
| Payout Consistency | 67.7% |
| Payout Ratio | 14.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 36.1% |
| Relative Tail Risk | -0.66% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.03 |
| Alpha | -19.41 |
| Character TTM | |
|---|---|
| Beta | 0.879 |
| Beta Downside | 1.280 |
| Drawdowns 3y | |
|---|---|
| Max DD | 28.03% |
| CAGR/Max DD | 0.50 |
Description: RRC Range Resources January 07, 2026
Range Resources Corp. (NYSE:RRC) is an independent U.S. producer of natural gas, natural gas liquids (NGLs) and oil, focused primarily on the Appalachian Basin (Marcellus and Utica shales). The company explores, develops and acquires assets, selling gas to utilities and industrial users, NGLs to petrochemical customers, and crude oil to refiners. Founded in 1976 (originally Lomak Petroleum) and headquartered in Fort Worth, Texas, RRC has transitioned to a leaner, cash-flow-driven model after a 2022 restructuring that cut debt by ~30%.
Key recent metrics: • 2023 average daily production was ~1.2 billion cubic feet of natural gas equivalent (Bcfe), a 5% rise YoY driven by higher Utica output. • Adjusted EBITDA for 2023 was $1.1 billion, reflecting a 12% margin improvement after cost-cutting initiatives. • The company’s debt-to-EBITDA ratio fell to 2.2×, below the industry median of ~3.0×, enhancing financial flexibility. • RRC’s cash-flow sensitivity is heavily linked to Henry Hub gas prices; a $0.30/MMBtu shift can swing annual free cash flow by ±$200 million. • Macro drivers include rising U.S. LNG export capacity, which supports long-term gas demand, and the ongoing shift toward lower-carbon energy sources that may pressure NGL pricing.
For a deeper quantitative view, the ValueRay platform provides a granular breakdown of RRC’s cash-flow sensitivity to gas-price scenarios and recent balance-sheet trends.
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 573.8m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.14 > 0.02 and ΔFCF/TA 9.26 > 1.0 |
| NWC/Revenue: -9.07% < 20% (prev -24.46%; Δ 15.38% < -1%) |
| CFO/TA 0.16 > 3% & CFO 1.13b > Net Income 573.8m |
| Net Debt (1.37b) to EBITDA (1.14b): 1.21 < 3 |
| Current Ratio: 0.56 > 1.5 & < 3 |
| Outstanding Shares: last quarter (239.0m) vs 12m ago -1.48% < -2% |
| Gross Margin: 34.37% > 18% (prev 0.25%; Δ 3412 % > 0.5%) |
| Asset Turnover: 39.73% > 50% (prev 32.09%; Δ 7.64% > 0%) |
| Interest Coverage Ratio: 7.02 > 6 (EBITDA TTM 1.14b / Interest Expense TTM 109.5m) |
Altman Z'' -0.38
| A: -0.04 (Total Current Assets 334.8m - Total Current Liabilities 595.1m) / Total Assets 7.20b |
| B: -0.15 (Retained Earnings -1.07b / Total Assets 7.20b) |
| C: 0.11 (EBIT TTM 768.6m / Avg Total Assets 7.22b) |
| D: -0.36 (Book Value of Equity -1.06b / Total Liabilities 2.99b) |
| Altman-Z'' Score: -0.38 = B |
Beneish M 1.00
| DSRI: 1.07 (Receivables 239.2m/181.1m, Revenue 2.87b/2.32b) |
| GMI: 0.71 (GM 34.37% / 24.51%) |
| AQI: 58.22 (AQ_t 0.93 / AQ_t-1 0.02) |
| SGI: 1.23 (Revenue 2.87b / 2.32b) |
| TATA: -0.08 (NI 573.8m - CFO 1.13b) / TA 7.20b) |
| Beneish M-Score: 30.79 (Cap -4..+1) = D |
What is the price of RRC shares?
Over the past week, the price has changed by -3.38%, over one month by +7.06%, over three months by -0.19% and over the past year by -1.87%.
Is RRC a buy, sell or hold?
- StrongBuy: 7
- Buy: 2
- Hold: 15
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the RRC price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 40.5 | 10.9% |
| Analysts Target Price | 40.5 | 10.9% |
| ValueRay Target Price | 40.6 | 11.1% |
RRC Fundamental Data Overview February 02, 2026
P/E Forward = 10.0301
P/S = 3.1179
P/B = 2.1109
P/EG = 2.9079
Revenue TTM = 2.87b USD
EBIT TTM = 768.6m USD
EBITDA TTM = 1.14b USD
Long Term Debt = 1.22b USD (from longTermDebt, last quarter)
Short Term Debt = 60.4m USD (from shortTermDebt, last quarter)
Debt = 1.37b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.37b USD (from netDebt column, last quarter)
Enterprise Value = 10.39b USD (9.02b + Debt 1.37b - CCE 175.0k)
Interest Coverage Ratio = 7.02 (Ebit TTM 768.6m / Interest Expense TTM 109.5m)
EV/FCF = 10.58x (Enterprise Value 10.39b / FCF TTM 982.2m)
FCF Yield = 9.46% (FCF TTM 982.2m / Enterprise Value 10.39b)
FCF Margin = 34.24% (FCF TTM 982.2m / Revenue TTM 2.87b)
Net Margin = 20.00% (Net Income TTM 573.8m / Revenue TTM 2.87b)
Gross Margin = 34.37% ((Revenue TTM 2.87b - Cost of Revenue TTM 1.88b) / Revenue TTM)
Gross Margin QoQ = 25.43% (prev 35.06%)
Tobins Q-Ratio = 1.44 (Enterprise Value 10.39b / Total Assets 7.20b)
Interest Expense / Debt = 1.77% (Interest Expense 24.3m / Debt 1.37b)
Taxrate = 21.29% (39.0m / 183.3m)
NOPAT = 605.0m (EBIT 768.6m * (1 - 21.29%))
Current Ratio = 0.56 (Total Current Assets 334.8m / Total Current Liabilities 595.1m)
Debt / Equity = 0.33 (Debt 1.37b / totalStockholderEquity, last quarter 4.20b)
Debt / EBITDA = 1.21 (Net Debt 1.37b / EBITDA 1.14b)
Debt / FCF = 1.40 (Net Debt 1.37b / FCF TTM 982.2m)
Total Stockholder Equity = 4.05b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.95% (Net Income 573.8m / Total Assets 7.20b)
RoE = 14.16% (Net Income TTM 573.8m / Total Stockholder Equity 4.05b)
RoCE = 14.59% (EBIT 768.6m / Capital Employed (Equity 4.05b + L.T.Debt 1.22b))
RoIC = 10.99% (NOPAT 605.0m / Invested Capital 5.51b)
WACC = 8.12% (E(9.02b)/V(10.39b) * Re(9.15%) + D(1.37b)/V(10.39b) * Rd(1.77%) * (1-Tc(0.21)))
Discount Rate = 9.15% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -33.33 | Cagr: -0.56%
[DCF Debug] Terminal Value 79.38% ; FCFF base≈716.5m ; Y1≈811.1m ; Y5≈1.10b
Fair Price DCF = 72.20 (EV 18.48b - Net Debt 1.37b = Equity 17.11b / Shares 236.9m; r=8.12% [WACC]; 5y FCF grow 15.39% → 2.90% )
EPS Correlation: -60.34 | EPS CAGR: -53.89% | SUE: -4.0 | # QB: 0
Revenue Correlation: -67.07 | Revenue CAGR: -15.94% | SUE: -0.89 | # QB: 0
EPS next Quarter (2026-03-31): EPS=1.00 | Chg30d=+0.010 | Revisions Net=-2 | Analysts=19
EPS next Year (2026-12-31): EPS=3.50 | Chg30d=-0.215 | Revisions Net=-9 | Growth EPS=+23.2% | Growth Revenue=+8.4%